Calvete, O.; Mestre, J.; Risueño, R.M.; Manzanares, A.; Acha, P.; Xicoy, B.; Solé, F.
Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms. Biomedicines 2023, 11, 3222.
https://doi.org/10.3390/biomedicines11123222
AMA Style
Calvete O, Mestre J, Risueño RM, Manzanares A, Acha P, Xicoy B, Solé F.
Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms. Biomedicines. 2023; 11(12):3222.
https://doi.org/10.3390/biomedicines11123222
Chicago/Turabian Style
Calvete, Oriol, Julia Mestre, Ruth M. Risueño, Ana Manzanares, Pamela Acha, Blanca Xicoy, and Francesc Solé.
2023. "Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms" Biomedicines 11, no. 12: 3222.
https://doi.org/10.3390/biomedicines11123222
APA Style
Calvete, O., Mestre, J., Risueño, R. M., Manzanares, A., Acha, P., Xicoy, B., & Solé, F.
(2023). Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms. Biomedicines, 11(12), 3222.
https://doi.org/10.3390/biomedicines11123222
